Suchen
Liminatus Pharma Ord Shs Class A
LIMNZur Watchlist hinzufügen
4.180USD
+0.150+3.72%
Handelsschluss 09-24 16:00（ET）
280.73MMarktkapitalisierung
VerlustKGV TTM
Über Unternehmen
Liminatus Pharma Ord Shs Class A Profil
Börsenkürzel- -
Name des Unternehmens- -
IPO-datum- -
CEO- -
Anzahl der mitarbeiter- -
Wertpapierart- -
Geschäftsjahresende- -
Addresse- -
Stadt- -
Börse- -
Land- -
Postleitzahl- -
Telefon- -
Website- -
Börsenkürzel- -
IPO-datum- -
CEO- -
Führungskräfte von Liminatus Pharma Ord Shs Class A
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Nicholas Fernandez
Mr. Nicholas Fernandez
Independent Director
Independent Director
333.00
--
Mr. Nicholas Fernandez
Mr. Nicholas Fernandez
Independent Director
Independent Director
333.00
--
Mr. Nicholas Fernandez
Mr. Nicholas Fernandez
Independent Director
Independent Director
333.00
--
Mr. Scott Dam
Mr. Scott Dam
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Sang-jin (Daniel) Lee, Ph.D.
Dr. Sang-jin (Daniel) Lee, Ph.D.
Head - Research & Development
Head - Research & Development
--
--
Dr. Byong Chul Yoo, Ph.D.
Dr. Byong Chul Yoo, Ph.D.
Chief Science Officer
Chief Science Officer
--
--
Dr. Beom K. Choi
Dr. Beom K. Choi
Chief Technology Officer
Chief Technology Officer
--
--
Mr. Philip Lemons
Mr. Philip Lemons
Independent Director
Independent Director
--
--
Mr. Richard Baek
Mr. Richard Baek
Independent Director
Independent Director
--
--
Mr. Chris Kim
Mr. Chris Kim
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Nicholas Fernandez
Mr. Nicholas Fernandez
Independent Director
Independent Director
333.00
--
Mr. Nicholas Fernandez
Mr. Nicholas Fernandez
Independent Director
Independent Director
333.00
--
Mr. Nicholas Fernandez
Mr. Nicholas Fernandez
Independent Director
Independent Director
333.00
--
Mr. Scott Dam
Mr. Scott Dam
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Sang-jin (Daniel) Lee, Ph.D.
Dr. Sang-jin (Daniel) Lee, Ph.D.
Head - Research & Development
Head - Research & Development
--
--
Dr. Byong Chul Yoo, Ph.D.
Dr. Byong Chul Yoo, Ph.D.
Chief Science Officer
Chief Science Officer
--
--
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Liminatus Pharma Ord Shs Class A?
Die fünf größten Anteilseigner von Liminatus Pharma Ord Shs Class A sind: Mr. Nicholas Fernandez